DMKJ
David M. Knott Jr Portfolio holdings
AUM
$221M
This Quarter Return
+12.82%
1 Year Return
+22.52%
3 Year Return
+148.91%
5 Year Return
–
10 Year Return
–
AUM
$221M
AUM Growth
+$221M
(+4.1%)
Cap. Flow
-$7.42M
Cap. Flow
% of AUM
-3.36%
Top 10 Holdings %
Top 10 Hldgs %
71.57%
Holding
93
New
9
Increased
15
Reduced
13
Closed
8
Top Buys
| 1 |
BridgeBio Pharma
BBIO
|
$3.45M |
| 2 |
LENZ
LENZ Therapeutics
LENZ
|
$2.4M |
| 3 |
Syndax Pharmaceuticals
SNDX
|
$2.11M |
| 4 |
Alkermes
ALKS
|
$1.4M |
| 5 |
Liquidia Corp
LQDA
|
$1.12M |
Top Sells
| 1 |
Pfizer
PFE
|
$4.36M |
| 2 |
VRNA
Verona Pharma
VRNA
|
$3.12M |
| 3 |
Janus Henderson AAA CLO ETF
JAAA
|
$2.87M |
| 4 |
Ardelyx
ARDX
|
$2.42M |
| 5 |
OmniAb
OABI
|
$2.36M |
Sector Composition
| 1 | Healthcare | 31.49% |
| 2 | Materials | 24.07% |
| 3 | Financials | 19.36% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 1.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Blackstone
BX
$132B
| $31.4K | 0.01% |
210
| – | – |
|
77
Occidental Petroleum
OXY
$47.3B
| $24K | 0.01% |
663
| – | – |
|
78
Salesforce
CRM
$242B
| $21K | 0.01% |
77
| – | – |
|
79
Thermo Fisher Scientific
TMO
$184B
| $18.2K | 0.01% |
45
| – | – |
|
80
Kyndryl
KD
$7.21B
| $18K | 0.01% |
428
| – | – |
|
81
UnitedHealth
UNH
$280B
| $17.8K | 0.01% |
57
| – | – |
|
82
Starwood Property Trust
STWD
$7.38B
| $8.03K | ﹤0.01% |
400
| – | – |
|
83
GE HealthCare
GEHC
$32.7B
| $3.7K | ﹤0.01% |
50
| – | – |
|
84
Wabtec
WAB
$32.9B
| $1.26K | ﹤0.01% |
6
| – | – |
|
|
85
Ardelyx
ARDX
$1.54B
| – | – |
-493,807
| Closed | -$2.42M |
|
86
Panagram AAA CLO ETF
CLOX
$220M
| – | – |
-5,766
| Closed | -$147K |
|
87
Cogent Biosciences
COGT
$1.68B
| – | – |
-213,302
| Closed | -$1.28M |
|
88
Invesco AAA CLO Floating Rate Note ETF
ICLO
$344M
| – | – |
-70,502
| Closed | -$1.8M |
|
89
Immunovant
IMVT
$2.63B
| – | – |
-22,443
| Closed | -$384K |
|
90
MeiraGTx Holdings
MGTX
$587M
| – | – |
-125,010
| Closed | -$848K |
|
|
91
OmniAb
OABI
$227M
| – | – |
-982,336
| Closed | -$2.36M |
|
92
Regeneron Pharmaceuticals
REGN
$61.3B
| – | – |
-2,000
| Closed | -$1.27M |
|